Ron Borsheim was appointed as Chief Sales Officer - Aesthetics at Zeo ScientifiX, Inc..
“Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.”
Zeo ScientifiX, Inc. — fact timeline
Source-grounded facts extracted from Zeo ScientifiX, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dr. Peter A. M. Everts was appointed as Chief Scientific and Technology Officer at Zeo ScientifiX, Inc..
“Effective February 7, 2025, Dr. Peter A. M. Everts, Ph.D. (“ Dr. Everts” ) was appointed the Company’s Chief Scientific and Technology Officer.”
Zeo ScientifiX, Inc.: Amended the Certificate of Designation of Series C Non-Convertible Preferred Stock to modify redemption provision (effective 2024-12-17).
“On December 17, 2024, we filed an Amendment (the “ Amendment ”) to the Certificate of Designation (the “ Certificate of Designation ”) of our Series C Non-Convertible Preferred Stock (the “ Series C Preferred Shares ”) with the Secretary of State of Nevada.”
Ian T. Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..
“Effective June 1, 2024, our board of directors appointed Ian T. Bothwell, the Company’s Chief Financial Officer to serve in the additional position of Interim Chief Executive Officer”
Dr. Howard Golub departed as Chief Science Officer at Zeo ScientifiX, Inc..
“the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.”
Dr. Harry Leider departed as Director at Zeo ScientifiX, Inc..
“Dr. Leider no longer serves as a director of ZEO, as provided for therein.”
Dr. Harry Leider departed as Chief Executive Officer at Zeo ScientifiX, Inc..
“the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.”
Zeo ScientifiX, Inc.: Changed company name from Organicell Regenerative Medicine, Inc. to Zeo ScientifiX, Inc (effective 2024-02-20).
“The Company has filed an Amendment to its Articles of Incorporation (the “ Amendment ”) with the Secretary of State of Nevada, changing its name from “ Organicell Regenerative Medicine, Inc. ” to “ Zeo ScientifiX, Inc. ” effective February 20, 2024.”
Zeo ScientifiX, Inc. completed a disposition involving a non-affiliated third party purchaser for $1,250,000 plus the assumption by Purchaser of all remaining financial and other obligations under the leases (closed 2023-08-07).
“the assignment of the leases for the Laboratory premises and certain laboratory equipment and the sale of leasehold improvements and inventory. The purchase price paid was $1,250,000 plus the assumption by Purchaser of all remaining financial and other obligations under the leases for the Laboratory premises and certain laboratory equipment. In addition,”
Dr. Maria Ines Mitrani resigned as director at Zeo ScientifiX, Inc..
“On July 11, 2023, Dr. Maria Ines Mitrani resigned as a director of the Company.”
Howard J. Golub was appointed as Executive Vice President and Chief Science Officer at Zeo ScientifiX, Inc..
“and Howard J. Golub, M.D., as Executive Vice President and Chief Science Officer.”
Harry Leider was appointed as Chief Executive Officer at Zeo ScientifiX, Inc..
“On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors”
Bhupendra Kumar Modi departed as Chairman of the Board at Zeo ScientifiX, Inc..
“On June 4, 2023, Dr. Bhupendra Kumar Modi stepped down as Chairman of the Board and a director of Organicell.”
Albert Mitrani was terminated as Executive Vice President of Sales at Zeo ScientifiX, Inc..
“On May 12, 2023, Organicell terminated Albert Mitrani as its Executive Vice President of Sales and contemporaneously terminated his employment agreement with the Company.”
Maria Ines Mitrani was terminated as Chief Scientific Officer at Zeo ScientifiX, Inc..
“On April 28, 2023, Organicell terminated Dr. Maria Ines Mitrani as its Chief Scientific Officer and contemporaneously terminated her employment agreement with the Company.”
Zeo ScientifiX, Inc. engaged Weinberg & Company P.A. as its auditor.
“On April 17 2023, the Audit Committee of our Board of Directors approved the appointment of Weinberg & Company P.A. (" Weinberg ") as the Company’s new independent registered public accounting firm.”
Zeo ScientifiX, Inc. incurred loan of $530,000 with AJB Capital Investments, LLC at 12% per annum maturing September 6, 2023.
“On March 6, 2023, the Company entered into a Securities Purchase Agreement (the “ SPA ”) with AJB Capital Investments, LLC (the “ Purchaser ”), pursuant to which we sold a Promissory Note in the principal amount of $530,000 (the “ Note ”) to the Purchaser in a private transaction to for a purchase price of $519,400 (giving effect to original issue discount of $10,600).”
Zeo ScientifiX, Inc. entered into Securities Purchase Agreement with AJB Capital Investments, LLC valued at $530,000 (effective 2023-03-06).
“On March 6, 2023, the Company entered into a Securities Purchase Agreement (the " SPA ") with AJB Capital Investments, LLC (the " Purchaser "), pursuant to which we sold a Promissory Note in the principal amount of $530,000”
John Chiste resigned as Director at Zeo ScientifiX, Inc..
“On December 21, 2022, John Chiste resigned as a member of the Company’s board of directors.”
Ian Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..
“The Board also agreed to appoint Mr. Ian Bothwell, the Company’s Chief Financial Officer to serve as the Company’s Interim Chief Executive Officer while the Board commences its process to identify suitable candidates to fill the Chief Executive Officer position.”
Matthew Sinnreich resigned as Acting Chief Executive Officer and President at Zeo ScientifiX, Inc..
“On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.”
Ryan Likes resigned as Chief Operating Officer at Zeo ScientifiX, Inc..
“On November 22, 2022, Ryan Likes resigned as the Company’s Chief Operating Officer.”
Matthew Sinnreich was appointed as Director at Zeo ScientifiX, Inc..
“At a meeting held on September 23, 2022, the Company’s board of directors (the “ Board ”) expanded the number of directors of the Company to thirteen (13) and appointed the following individuals to fill existing and newly-created vacancies on the Board: ● Matthew Sinnreich, our President and Acting Chief Executive Officer”
Matthew Sinnreich changed role as President at Zeo ScientifiX, Inc..
“Matthew Sinnreich, the Company’s current Chief Operating Officer and Acting Chief Executive Officer assumed the role of President and will continue as Organicell’s Acting Chief Executive Officer.”
Ryan Likes was appointed as Chief Operating Officer at Zeo ScientifiX, Inc..
“Effective September 13, 2022, Ryan Likes had joined the Company as its Chief Operating Officer.”
Matthew Sinnreich was appointed as Chief Operating Officer and Acting Chief Executive Officer at Zeo ScientifiX, Inc..
“On the Effective Date, Matthew Sinnreich was appointed by the Board of Directors to the position of Chief Operating Officer and Acting Chief Executive Officer.”
Albert Mitrani was appointed as Executive Vice President of Sales at Zeo ScientifiX, Inc..
“Effective July 21, 2022 (the “ Effective Date ”), Albert Mitrani stepped down as the Company’s Chief Executive Officer and was appointed by the Board of Directors to the position of Executive Vice President of Sales.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.